Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Keywords » - entrée « Comorbidity »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Community-Acquired Infections (pathology) < Comorbidity < Comparative Effectiveness Research  Facettes :

List of bibliographic references indexed by Comorbidity

Number of relevant bibliographic references: 19.
Ident.Authors (with country if any)Title
000880 (2019) Ajinkya Pawar [États-Unis] ; Rishi J. Desai [États-Unis] ; Daniel H. Solomon [États-Unis] ; Adrian J. Santiago Ortiz [États-Unis] ; Sara Gale [États-Unis] ; Min Bao [États-Unis] ; Khaled Sarsour [États-Unis] ; Sebastian Schneeweiss [États-Unis] ; Seoyoung C. Kim [États-Unis]Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study.
000A92 (2019) Ana F. Águeda [Portugal] ; Sara Monti [Italie] ; Raashid Ahmed Luqmani [Royaume-Uni] ; Frank Buttgereit [Allemagne] ; Maria Cid [Espagne] ; Bhaskar Dasgupta [Royaume-Uni] ; Christian Dejaco [Italie, Autriche] ; Alfred Mahr [France] ; Cristina Ponte [Portugal] ; Carlo Salvarani [Italie] ; Wolfgang Schmidt [Allemagne] ; Bernhard Hellmich [Allemagne]Management of Takayasu arteritis: a systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis
000B28 (2019) Abrar-Ahmad Zulfiqar [France] ; Rizwan Niazi [France] ; Jean-Loup Pennaforte [France] ; Emmanuel Andres [France]Late-onset rheumatoid arthritis: clinical, biological, and therapeutic features About a retrospective study.
000B89 (2019) Juan Shan [République populaire de Chine] ; Jiabi Zhang [République populaire de Chine]Impact of obesity on the efficacy of different biologic agents in inflammatory diseases: A systematic review and meta-analysis.
001160 (2018) Alexander Pfeil [Allemagne] ; Peter Oelzner [Allemagne] ; Peter Hellmann [Allemagne]The Treatment of Giant Cell Arteritis in Different Clinical Settings.
001301 (2018) Lisa Baganz [Allemagne] ; Adrian Richter [Allemagne] ; Jörn Kekow [Allemagne] ; Arnold Bussmann [Allemagne] ; Andreas Krause [Allemagne] ; Carsten Stille [Allemagne] ; Joachim Listing [Allemagne] ; Angela Zink [Allemagne] ; Anja Strangfeld [Allemagne]Long-term effectiveness of tocilizumab in patients with rheumatoid arthritis, stratified by number of previous treatment failures with biologic agents: results from the German RABBIT cohort.
001446 (2018) Ettore Silvagni [Italie] ; Alessandra Bortoluzzi [Italie] ; Greta Carrara [Italie] ; Anna Zanetti [Italie] ; Marcello Govoni [Italie] ; Carlo Alberto Scirè [Italie]Comparative effectiveness of first-line biological monotherapy use in rheumatoid arthritis: a retrospective analysis of the RECord-linkage On Rheumatic Diseases study on health care administrative databases.
001735 (2017) Katie Tuckwell [Royaume-Uni] ; Neil Collinson [Royaume-Uni] ; Sophie Dimonaco [Royaume-Uni] ; Micki Klearman [États-Unis] ; Daniel Blockmans [Belgique] ; Elisabeth Brouwer [Pays-Bas] ; Maria C. Cid [Espagne] ; Bhaskar Dasgupta [Royaume-Uni] ; Juergen Rech [Allemagne] ; Carlo Salvarani [Italie] ; Sebastian H. Unizony [États-Unis] ; John H. Stone [États-Unis]Newly diagnosed vs. relapsing giant cell arteritis: Baseline data from the GiACTA trial.
001815 (2017) Sara Monti [Italie] ; Catherine Klersy [Italie] ; Roberto Gorla [Italie] ; Piercarlo Sarzi-Puttini [Italie] ; Fabiola Atzeni [Italie] ; Raffaele Pellerito [Italie] ; Enrico Fusaro [Italie] ; Giuseppe Paolazzi [Italie] ; Pier Andrea Rocchetta [Italie] ; Ennio Giulio Favalli [Italie] ; Antonio Marchesoni [Italie] ; Roberto Caporali [Italie]Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis: real-life data from the Italian LORHEN Registry.
001845 (2017) C. Pérez-Sánchez [Espagne] ; P. Ruiz-Lim N [Espagne] ; M A Aguirre [Espagne] ; Y. Jiménez-G Mez [Espagne] ; I. Arias-De La Rosa [Espagne] ; M C Ábalos-Aguilera [Espagne] ; A. Rodriguez-Ariza [Espagne] ; M C Castro-Villegas [Espagne] ; R. Ortega-Castro [Espagne] ; P. Segui [Espagne] ; C. Martinez [Espagne] ; R. Gonzalez-Conejero [Espagne] ; S. Rodríguez-L Pez [Espagne] ; J A Gonzalez-Reyes [Espagne] ; J M Villalba [Espagne] ; E. Collantes-Estévez [Espagne] ; A. Escudero [Espagne] ; N. Barbarroja [Espagne] ; Ch L Pez-Pedrera [Espagne]Diagnostic potential of NETosis-derived products for disease activity, atherosclerosis and therapeutic effectiveness in Rheumatoid Arthritis patients.
002024 (2015) William Terreaux ; Stéphanie Mestrallet ; Marion Fauconier ; Jean-Loup Pennaforte [France] ; Christian Penalba ; Jean-Paul Eschard ; Jean-Hugues Salmon [France]Failure of tocilizumab therapy in a patient with mouth and genital ulcers with inflamed cartilage syndrome complicated by aortic aneurysm.
002106 (2015) Muhammad K. Nisar [Royaume-Uni] ; Aneesa Rafiq [Royaume-Uni] ; Andrew J K. Östör [Royaume-Uni]Biologic therapy for inflammatory arthritis and latent tuberculosis: real world experience from a high prevalence area in the United Kingdom.
002443 (2014) Sarah M. Keidel [Royaume-Uni] ; Rachel K. Hoyles ; Nick M R. WilkinsonEfficacy of tocilizumab for interstitial lung disease in an undifferentiated autoinflammatory disorder partially responsive to anakinra.
002722 (2013) Ratnesh Chopra [États-Unis] ; Nida Chaudhary ; Jonathan KayRelapsing polychondritis.
002823 (2013) L. Aguado-Gil [Espagne] ; I. Irarrazaval-Armendáriz ; M. Pretel-IrazabalAdvances in the diagnosis and treatment of tumor necrosis factor receptor-associated periodic syndrome.
003487 (2012) John M. Davis [États-Unis] ; Eric L. MattesonMy treatment approach to rheumatoid arthritis.
003501 (2012) Daisuke Hoshi [Japon] ; Ayako Nakajima ; Eisuke Inoue ; Kumi Shidara ; Eri Sato ; Mariko Kitahama ; Yohei Seto ; Eiichi Tanaka ; Wako Urano ; Naomi Ichikawa ; Yumi Koseki ; Shigeki Momohara ; Astuo Taniguchi ; Norihiro Nishimoto ; Hisashi YamanakaIncidence of serious respiratory infections in patients with rheumatoid arthritis treated with tocilizumab.
003939 (2011) G. Lapadula [Italie] ; G. Ferraccioli ; C. Ferri ; L. Punzi ; F. TrottaGISEA: an Italian biological agents registry in rheumatology.
004011 (2009) Yasuhiko Hirabayashi [Japon] ; Tomonori Ishii [Japon] ; Hideo Harigae [Japon]Clinical efficacy of tocilizumab in patients with active rheumatoid arthritis in real clinical practice

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Comorbidity" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Comorbidity" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Comorbidity
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021